Sequenom Inc. (Nasdaq: SQNM) and Illumina Inc. (Nasdaq: ILMN) settled all patent
infringement claims and will pool their noninvasive prenatal testing
intellectual properties. Shares of Sequenom climbed 74 cents to $3.79 while Illumina stock added 84 cents to $189.01.
Sequenom and Illumina settle patent claims
December 03, 2014 at 05:33 AM EST
